Found: 47
Select item for more details and to access through your institution.
Severe Insulin Resistance in a Patient Treated With Nivolumab and Brentuximab-Vedotin for Hodgkin Lymphoma.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 6, p. 1, doi. 10.1210/jcemcr/luad121
- By:
- Publication type:
- Article
Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin Lymphoma.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2024, p. 1, doi. 10.1177/23247096241255840
- By:
- Publication type:
- Article
Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2023, p. 1, doi. 10.1177/23247096231209543
- By:
- Publication type:
- Article
Brief report: risk stratification following curative therapy for stage I NSCLC.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1250315
- By:
- Publication type:
- Article
BRAF p.V600E associated poly-neoplastic syndrome.
- Published in:
- Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211012929
- By:
- Publication type:
- Article
BRAF p.V600E associated poly-neoplastic syndrome.
- Published in:
- Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211012929
- By:
- Publication type:
- Article
Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 429, doi. 10.1111/bjh.17700
- By:
- Publication type:
- Article
Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1011, doi. 10.1177/1078155218774895
- By:
- Publication type:
- Article
DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 739, doi. 10.1002/ajh.26888
- By:
- Publication type:
- Article
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
- By:
- Publication type:
- Article
Xanthogranulomatous Pyelonephritis: Synchronous Upper and Lower Gastrointestinal Bleed.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2019, v. 7, p. N.PAG, doi. 10.1177/2324709619842899
- By:
- Publication type:
- Article
Xanthogranulomatous Pyelonephritis: Synchronous Upper and Lower Gastrointestinal Bleed.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2019, v. 7, p. N.PAG, doi. 10.1177/2324709619842899
- By:
- Publication type:
- Article
Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2019, v. 7, p. N.PAG, doi. 10.1177/2324709619840375
- By:
- Publication type:
- Article
Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2019, v. 7, p. N.PAG, doi. 10.1177/2324709619840375
- By:
- Publication type:
- Article
A Challenging Case of Pseudohyperkalemia in Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2017, v. 5, n. 4, p. 1, doi. 10.1177/2324709617746194
- By:
- Publication type:
- Article
Myelomatous ascites and pleural effusion in relapsed multiple myeloma.
- Published in:
- Clinical Case Reports, 2022, v. 10, n. 2, p. 1, doi. 10.1002/ccr3.5329
- By:
- Publication type:
- Article
Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 5, p. 1, doi. 10.1002/ccr3.3971
- By:
- Publication type:
- Article
Systemic ALK‐positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 2629, doi. 10.1002/ccr3.3231
- By:
- Publication type:
- Article
Follicular lymphoma associated paraneoplastic myositis.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 10, p. 2003, doi. 10.1002/ccr3.3046
- By:
- Publication type:
- Article
Primary diffuse large B‐cell lymphoma presenting as acute appendicitis: A report of 2 cases and a literature review.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 2, p. 293, doi. 10.1002/ccr3.2653
- By:
- Publication type:
- Article
Paraneoplastic frosted branch angiitis as first sign of relapsed Hodgkin lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2022, v. 12, p. 17, doi. 10.2147/BLCTT.S353430
- By:
- Publication type:
- Article
<sup>90</sup>Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2022, v. 12, p. 47, doi. 10.2147/BLCTT.S362736
- By:
- Publication type:
- Article
Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 259, doi. 10.1016/j.clml.2023.01.010
- By:
- Publication type:
- Article
Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 138, doi. 10.1016/j.clml.2022.11.004
- By:
- Publication type:
- Article
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 618, doi. 10.1016/j.clml.2022.03.004
- By:
- Publication type:
- Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
- By:
- Publication type:
- Article
Clinical Characteristics and Survival Outcomes of Primary Effusion Lymphoma: A National Cancer Database Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e485, doi. 10.1016/j.clml.2022.01.006
- By:
- Publication type:
- Article
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
- By:
- Publication type:
- Article
ABCL-062: Primary Effusion Lymphoma: Clinical Characteristics and Natural History.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S379, doi. 10.1016/S2152-2650(21)01864-4
- By:
- Publication type:
- Article
Poster: ABCL-062: Primary Effusion Lymphoma: Clinical Characteristics and Natural History.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S242, doi. 10.1016/S2152-2650(21)01521-4
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
- By:
- Publication type:
- Article
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Colchicine as an Alternative First-Line Treatment of Sclerosing Mesenteritis: A Retrospective Study.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 6, p. 2403, doi. 10.1007/s10620-021-07081-4
- By:
- Publication type:
- Article
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 695, doi. 10.1002/hon.3012
- By:
- Publication type:
- Article
A skin rash and what lies beneath: Paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 822, doi. 10.1002/ajh.23471
- By:
- Publication type:
- Article
Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report.
- Published in:
- Journal of Blood Medicine, 2024, v. 15, p. 29, doi. 10.2147/JBM.S444004
- By:
- Publication type:
- Article
Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy.
- Published in:
- Journal of Blood Medicine, 2023, v. 14, p. 455, doi. 10.2147/JBM.S405521
- By:
- Publication type:
- Article
Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma.
- Published in:
- Journal of Blood Medicine, 2023, v. 14, p. 49, doi. 10.2147/JBM.S391094
- By:
- Publication type:
- Article
Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 663, doi. 10.2147/JBM.S384983
- By:
- Publication type:
- Article
Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 833, doi. 10.2147/JBM.S328529
- By:
- Publication type:
- Article
Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 645, doi. 10.2147/JBM.S325264
- By:
- Publication type:
- Article
Ibritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2079, doi. 10.1002/onco.13895
- By:
- Publication type:
- Article